Peter Pertel
Novartis (United States)(US)
Publications by Year
Research Areas
Malaria Research and Control, Cytomegalovirus and herpesvirus research, Herpesvirus Infections and Treatments, Spondyloarthritis Studies and Treatments, Antimicrobial Resistance in Staphylococcus
Most-Cited Works
- → Cell Fusion Induced by Herpes Simplex Virus Glycoproteins gB, gD, and gH-gL Requires a gD Receptor but Not Necessarily Heparan Sulfate(2001)288 cited
- Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus.(1992)
- → Clinical Characteristics and Functional Outcomes of West Nile Fever(2004)212 cited
- → Effects of Prior Effective Therapy on the Efficacy of Daptomycin and Ceftriaxone for the Treatment of Community‐Acquired Pneumonia(2008)160 cited
- → Risk of Developing Cytomegalovirus Retinitis in Persons Infected With the Human Immunodeficiency Virus(1993)137 cited
- → Human Herpesvirus 8 Glycoprotein B (gB), gH, and gL Can Mediate Cell Fusion(2002)127 cited
- → Randomized Controlled Trial of Moxifloxacin Compared With Piperacillin???Tazobactam and Amoxicillin???Clavulanate for the Treatment of Complicated Intra-abdominal Infections(2006)119 cited
- → Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria(2016)107 cited
- → A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Antimalarial Spiroindolone KAE609 (Cipargamin) To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers(2014)104 cited
- → Multicenter, Randomized Clinical Trial To Compare the Safety and Efficacy of LFF571 and Vancomycin for Clostridium difficile Infections(2014)100 cited